The 13th Cell Therapy Conference is hosted by Beijing Jing-Meng Stem Cell Technology Co., Ltd. on March 3rd, 2018. The conference is with the theme of ‘don't forget the medical principles and return to the original intention’. President of Jing-Meng,
The 13th Cell Therapy Conference on Site
The 13th Cell Therapy Conference is hosted by Beijing Jing-Meng Stem Cell Technology Co., Ltd. on March 3rd, 2018. The conference is with the theme of ‘don't forget the medical principles and return to the original intention’. President of Jing-Meng, Dr. Gao, points out that in his speech that "What is the first goal of all these years as a great health worker? It is for the public health, for the treatment of disease. So we should return to our original intention and do our best to eradicate disease and keep healthy.”
Leaders as Dr. Yu Xiaodong, director of the National Public Nutrition Improvement Program, Chairman Zhang Yi, China's urban development committee of European Union, Mr. Xu Fengjun, former Director of the Science and Technology Department of Inner Mongolia Autonomous Region, Professor Xiao Qinfu, Central Committee of the Communist Party of China Party School, President Qin Qingyun, magazine of Liao Wang China, Qu Yongzhong, Fu Wai Hospital former secretary of the party committee, give speeches respectively. The leaders have raised common expectations for Jing-Meng and expect her to become an industry leader and make greater efforts in standardization and international operation.
Expert technical reports are given priority in the morning. Executive director of Beijing Lu Daopei Hospital, Li Dinggang, makes report on ‘stem cell regenerative medicine and the new opportunities of the development of international medical tourism industry in China’. in the report, Li analyzes of the current medical tourism industry, puts forward China should release of production capacity in this emerging industry.
The report of professor Zhang Jinguang, director of the Liver Transplantation Center of Beijing You 'An Hospital, is ‘accurate clinical diagnosis and treatment of liver cirrhosis with hepatic tumor decompensation’. Professor Zhang reports a case of a Cambodian patient with liver cirrhosis, liver cancer, hepatitis C, alcoholic liver and so on. After a month treatment with cell therapy and other comprehensive methods, the patients has been from C level reached A level, and his state is very good.
Professor Chen Zhongcun, director of Plastic Surgery Department, Fu Xing Hospital, makes a report entitled ‘international anti-aging five-dimensional health and beauty model establishment and implementation’. Professor Chen points out that the five dimensions focus on people's energy, using the latest cell technology, let a person not only in form, more important is display on psychological expression and the heart, also to make people reach a higher level in both physically and mentally.
Lin Zhigong, Executive Vice President of Jing-Meng, gives report from Jing-Meng business and future planning. Jing-Meng’s five business sectors are: bio-bank, cell preparation, molecular and cellular diagnosis, Jing-Meng Healthcare, precision medical. In the next three years to five years, Jing-Meng will occupy a certain position in the world cell industry.
In the afternoon, various companies of Jing-Meng Group and their subordinate departments introduce the business development and launch some products. Precision medicine, technology system of Cellular and Molecular Diagnosis, operation system, operation system, business and development of Jing-Meng Bio-technology Company, Jing-Meng Healthcare and Jing-Meng Biobank are respectively introduced. Jing-Meng Healthcare also releases the ‘life code’ product. Jing-Meng Bio-technology also launches more than a dozen fist products including elite liquid products.
The 13th Cell Therapy Conference ends in that evening. With the background of great health industry becoming a key industry, Jing-Meng Group is confident to usher in the spring of 2018.